Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06951867

Tezspire Cardiac Events PASS

Conditions: Cardiovascular Events, MACE

Sex: All

Ages: 12 Years – 130 Years

Healthy volunteers: No

Enrollment: 16640

Sponsor: AstraZeneca

Location: Healthcare Integrated Research Database (HIRD) Wilmington Delaware

Summary

The aim of this study is to evaluate the risk of serious adverse cardiovascular events in adolescent and adult patients with severe asthma taking tezepelumab compared to a population receiving standard of care treatment for severe asthma.

Eligibility Criteria

Inclusion Criteria: * patients with a diagnosis of asthma receiving tezepelumab or high-intensity SOC treatment for severe asthma at any point during the study inclusion period. Exclusion Criteria for both exposed and unexposed groups include: * \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06951867). StuddyBuddy aggregates publicly available trial information.